Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry

Not Recruiting

Trial ID: NCT01144780

Purpose

The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.

Official Title

Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry

Stanford Investigator(s)

Jason Gotlib

Professor of Medicine (Hematology)

Eligibility


Inclusion Criteria:Any patient who carries a diagnosis of a myeloproliferative disorder
(MPD). Exclusion Criteria:Any patient who is not willing to give consent.

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Stephen Oh
650-723-7875

New Trial Alerts